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ABSTRACT 
 
THE CORRELATION OF INTERLEUKIN-10-1082G/A GENES POLYMORFISM 
WITH HEARING LOSS IN PULMONARY MULTIDRUGS RESISTANT-
TUBERCULOSIS PATIENTS 
 
Dramora Nepy Asmara 
 
Introduction: Problems of tuberculosis (TB) eradication were increased with the presence of 
Mycobacterium tuberculosis (MTb) resistance to anti-TB drugs called MDR-TB. Genotype 
IL-10-1082G/A polymorphisms associated with the secretion of interleukin 10 (IL-10) as an 
anti-inflammatory cytokine play important role in the pathogenesis of MDR-TB infection. 
Management of MDR-TB using OAT kanamycin cause the effects of ototoxicity resulting in 
deafness. The IL-10 protective role of IL-10-1082G/A genotype against deafness due to 
kanamycin remains controversial.  
Methods: Observational studies of cohort retrospective analysis of patients with MDR-TB 
treated at RSUD Dr. Moewardi Surakarta in 2011-2015.  
Results: There were 81 subjects MDR-TB patients with genotype IL-10-1082G/A 
polymorphism. The proportion of IL-10-1082G/A paired allele genotypes were AA 9.9%, 
GG 4.9%, and GA 69%. Patients with MDR-TB with kanamycin therapy who experienced 
deafness were 55.5% with p=0.899 did not statistically significant. The degree of right ear 
audiometry p=0.375 whereas the left ear p=0.416 shows no significant association with IL-
10-1082G/A genotype polymorphism. The mean onset of deafness of the three groups of 
polymorphisms was 2.51 ± 2.88 months after injection obtaining a statistically insignificant 
p=0.758 with IL-10-1082G/A genotype polymorphism. Polymorphisms in the GA genotype 
(55.1%) tend to had lower ototoxicity than the AA genotype (62.5%). GA genotype showed 
protective effect against deafness compared to other genotypes.  
Conclusions: There is no correlation between interleukin genotype polymorphism 10-
1082G/A with deafness in MDR-TB patients. There is no correlation between interleukin 
genotype polymorphism 10-1082G/A with onset of deafness in MDR-TB patients.  
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